Zantac Cancer Lawsuits
Experienced Attorneys Pursuing Justice for Those Injured by Zantac
Zantac (ranitidine) has been recalled by the United States Food and Drug Administration (FDA) after low levels of a potentially toxic substance was found in the medication. If you have developed a serious health condition, such as cancer, after taking brand-name Zantac or a generic, over-the-counter (OTC) version of it, reach out to our attorneys at Rosenberg & Rosenberg, P.A. to discuss your legal options.
Individuals have the legal right to be warned of any dangers that may be present in the medications they purchase or are prescribed. When people are put at risk of being hurt without their consent, especially when that risk pans out into an injury, the law grants them the right to pursue justice against the responsible party via a legal claim.
Call Rosenberg & Rosenberg, P.A. at (888) 499-6206 today to discuss your Zantac cancer lawsuit.
FDA Zantac Investigation Ends in Nationwide Recall
Zantac is a commonplace antacid prescription medication. It belongs to a class of drugs known as histamine H2-receptor antagonists, or H2-blockers, and is typically taken in doses of 75, 150, or 300 mg to treat heartburn and acid reflux, among other digestive tract issues. Unfortunately, its widespread use means that it has affected countless individuals over the years. What’s worse, USA Today reported that Zantac’s health risks were first suspected and potentially known as far back as the 1980s — the same decade the medication first went to market.
Yet it was not until 2019 when the FDA announced that Zantac (and some other ranitidine medications) were found to contain low levels of a potential carcinogen called N-Nitrosodimethylamine (NDMA), also known as dimethylnitrosamine. Then, in 2020, the FDA issued a recall of all ranitidine drugs, including Zantac, from the market after determining that the levels of NDMA in them may increase over time when stored in places that are higher than room temperature.
Can I File a Zantac Cancer Lawsuit?
If you or a loved one has a history of taking Zantac — brand-name or generic — and developed cancer or any other health condition you were not warned about as a result, you likely have grounds to file a claim. Numerous Zantac mass torts and class actions are currently pending, and there is still time for you to bring forth your own lawsuit. Should you win, you may be entitled to damages including medical expenses, lost earnings, loss of enjoyment of life, pain and suffering, emotional distress, and more.
Who Can Be Held Accountable?
Zantac was first manufactured by GlaxoSmithKline (GSK) in 1977 and went to market with the FDA’s approval in 1983. In 1984, a generic brand became available. Then in 2004, Pfizer made its own OTC version of the drug, which was bought by Boehringer Ingelheim in 2006, then Sanofi in 2017. Overall, there are 20 different companies that have manufactured and distributed ranitidine as a tablet, capsule, and/or syrup. Therefore, various manufacturers are behind brand-name and generic Zantac and can be held accountable for defective design and the failure to warn consumers of the drug’s risks.
Our Lawyers Advocate for Consumer Safety
At Rosenberg & Rosenberg, P.A., we are passionate about protecting the rights of consumers nationwide by holding those who harm them accountable. With more than 50 years of legal experience, our lawyers are prepared to carry out an intensive investigation into the nuances of your claim and relentlessly fight against the large corporation responsible. Our dedication to our clients has resulted in six- and seven-figure jury verdicts and settlements in their favor. Don’t settle for less. Work with attorneys who truly care about you and your recovery.
Contact us online today to schedule a free consultation with a Fort Lauderdale attorney.
Good morning gentlemen. I am writing this email in regards to a Workmen's Comp. case that Rosenberg and Rosenberg handle for me. I felt compelled to send you this email. I am just finishing a long Workmans comp case that Matthew was handling for me. Mat”- Norman M.